Arrhythmogenic Right Ventricular Cardiomyopathy

Uncommon inherited condition that predominantly affects the right ventricle with fatty or fibro-fatty replacement of myocytes, leading to segmental or global dilation

Aetiology

  • Autosomal dominant and autosomal recessive forms have been identified, mutations mostly involve desmosomal genes

Pathophysiology

  • Fibro-fatty replacement of cardiomyocytes in right ventricle
  • LV involvement in >50% of cases

Clinical presentation

  • Most patients are symptomatic
  • When present, symptoms include symptomatic ventricular arrhythmia, syncope, or sudden death

Investigations

  • ECG - usually normal
  • Imaging - echo, cardiac MRI
  • Genetic testing

Management

  • β-blockers are first-line treatment for patients with non-life-threatening arrhythmias
  • Amiodarone or sotalol is used for symptomatic arrhythmias
  • For refractory or life-threatening arrhythmias an ICD is required